These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 27133178)
1. In vitro effect of imatinib mesylate loaded on polybutylcyanoacrylate nanoparticles on leukemia cell line K562. Hasandoost L; Akbarzadeh A; Attar H; Heydarinasab A Artif Cells Nanomed Biotechnol; 2017 May; 45(3):665-669. PubMed ID: 27133178 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of 10-hydroxycamptothecin-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization. Jin X; Asghar S; Zhu X; Chen Z; Tian C; Yin L; Ping Q; Xiao Y Colloids Surf B Biointerfaces; 2018 Feb; 162():25-34. PubMed ID: 29145001 [TBL] [Abstract][Full Text] [Related]
3. Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved Properties as an Anticancer Agent. Alavi SE; Muflih Al Harthi S; Ebrahimi Shahmabadi H; Akbarzadeh A Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934689 [TBL] [Abstract][Full Text] [Related]
4. [Preparation and in vitro release characteristics of vincristine sulphate loaded poly (butylcyanoacrylate) nanoparticles]. Tan R; Liu Y; Feng N; Zhao J Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(11):1431-5. PubMed ID: 22779171 [TBL] [Abstract][Full Text] [Related]
5. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles. Duan J; Mansour HM; Zhang Y; Deng X; Chen Y; Wang J; Pan Y; Zhao J Int J Pharm; 2012 Apr; 426(1-2):193-201. PubMed ID: 22274587 [TBL] [Abstract][Full Text] [Related]
6. QbD-based co-loading of paclitaxel and imatinib mesylate by protamine-coated PLGA nanoparticles effective on breast cancer cells. Laxane N; Yadav KS Nanomedicine (Lond); 2024; 19(26):2211-2227. PubMed ID: 38934510 [TBL] [Abstract][Full Text] [Related]
7. Controlled release and anti-proliferative effect of imatinib mesylate loaded sporopollenin microcapsules extracted from pollens of Betula pendula. Sargin I; Akyuz L; Kaya M; Tan G; Ceter T; Yildirim K; Ertosun S; Aydin GH; Topal M Int J Biol Macromol; 2017 Dec; 105(Pt 1):749-756. PubMed ID: 28716746 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers. He M; Zhao Z; Yin L; Tang C; Yin C Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302 [TBL] [Abstract][Full Text] [Related]
9. Encapsulation of Imatinib in Targeted KIT-5 Nanoparticles for Reducing its Cardiotoxicity and Hepatotoxicity. Varshosaz J; Fardshouraki S; Mirian M; Safaeian L; Jandaghian S; Taymouri S Anticancer Agents Med Chem; 2020; 20(16):1966-1980. PubMed ID: 32560620 [TBL] [Abstract][Full Text] [Related]
10. Delivery as nanoparticles reduces imatinib mesylate-induced cardiotoxicity and improves anticancer activity. Marslin G; Revina AM; Khandelwal VK; Balakumar K; Prakash J; Franklin G; Sheeba CJ Int J Nanomedicine; 2015; 10():3163-70. PubMed ID: 25995626 [TBL] [Abstract][Full Text] [Related]
11. Hydrophobic lapatinib encapsulated dextran-chitosan nanoparticles using a toxic solvent free method: fabrication, release property & in vitro anti-cancer activity. Mobasseri R; Karimi M; Tian L; Naderi-Manesh H; Ramakrishna S Mater Sci Eng C Mater Biol Appl; 2017 May; 74():413-421. PubMed ID: 28254312 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer. Ren F; Chen R; Wang Y; Sun Y; Jiang Y; Li G Pharm Res; 2011 Apr; 28(4):897-906. PubMed ID: 21184150 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of in-vitro cytotoxicity and cellular uptake efficiency of zidovudine-loaded solid lipid nanoparticles modified with Aloe Vera in glioma cells. K S J; Sharma CP; Kalarikkal N; Sandeep K; Thomas S; Pothen LA Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():40-50. PubMed ID: 27207037 [TBL] [Abstract][Full Text] [Related]
15. [Preparation of paclitaxel-loaded polybutylcyanoacrylate nanoparticles]. Chen RD; Ren F; Li GF; Liu SJ Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):763-6. PubMed ID: 20423845 [TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of polybutylcyanoacrylate magnetic nanoparticles. Ren F; Chen JH; Jiang YD; Chen ZL Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):161-3. PubMed ID: 14965816 [TBL] [Abstract][Full Text] [Related]
17. Coupled delivery of imatinib mesylate and doxorubicin with nanoscaled polymeric vectors for a sustained downregulation of BCR-ABL in chronic myeloid leukemia. Palamà IE; Cortese B; D'Amone S; Arcadio V; Gigli G Biomater Sci; 2015 Feb; 3(2):361-72. PubMed ID: 26218127 [TBL] [Abstract][Full Text] [Related]
18. Syntheses and biological evaluation of 1,2,3-triazole and 1,3,4-oxadiazole derivatives of imatinib. Li YT; Wang JH; Pan CW; Meng FF; Chu XQ; Ding YH; Qu WZ; Li HY; Yang C; Zhang Q; Bai CG; Chen Y Bioorg Med Chem Lett; 2016 Mar; 26(5):1419-27. PubMed ID: 26850004 [TBL] [Abstract][Full Text] [Related]
19. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres. Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657 [TBL] [Abstract][Full Text] [Related]
20. Temperature-sensitive liposomes for co-delivery of tamoxifen and imatinib for synergistic breast cancer treatment. Jose A; Ninave KM; Karnam S; Venuganti VVK J Liposome Res; 2019 Jun; 29(2):153-162. PubMed ID: 30022700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]